Galena Biopharma To Present At The Rodman And Renshaw 14th Annual Investment Conference

LAKE OSWEGO, Ore., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and CEO, will present a corporate overview at the Rodman and Renshaw 14 th Annual Healthcare Conference. The presentation will take place on Monday, September 10, 2012 at 2:50 p.m. EDT at the Waldorf Astoria Hotel in New York, NY.

The presentation will be webcast and available on the Company's website at http://investors.galenabiopharma.com/events.cfm.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com.

The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647
CONTACT: Madeline Hatton         Toll free: +1 (855) 855-GALE (4253), ext. 109         info@galenabiopharma.com                  or                  Remy Bernarda         IR Sense, LLC         +1 (415) 203-6386         remy@irsense.com

Galena Biopharma, Inc.

More from Press Releases

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

21st Century Fox Scoops Up Local News Stations

21st Century Fox Scoops Up Local News Stations

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Three-Part FREE Webinar Series

Three-Part FREE Webinar Series

March 24 Full-Day Course Offering: Professional Approach to Trading SPX

March 24 Full-Day Course Offering: Professional Approach to Trading SPX